2023 SPEAKERS
Anthony Adamkovic, Senior Director of Pharmacovigilance, Harmony Biosciences, LLC
Vivek Ahuja, Senior Vice President, Global Delivery Excellence, Strategy & Growth, PV, Quality & Regulatory Service Lines, Eversana
Omar Aimer, Executive Committee member of ISoP; Founder of, Innovigilance
Vikram Anand, President, Compliance Service Line, Eversana
Anand Ananthakrishnan, Senior Director of Drug Safety and Pharmacovigilance, Blueprint
Maria Anitan, Global Head of Pharmacovigilance and Drug Safety, Med Communications Inc
Felix Arellano, Global Head of Safety and Risk Management, F.Hoffmann-La Roche
Jamal Baig, Multi Country Safety Head - South Asia & Indo-China, Sanofi
Nicole Baker, CEO, biologit
Greg Ball, Safety Data Scientist, ASAP Process
Christina Barker, Senior Director, Product Management Safety & AIML, ArisGlobal LLC
Victoria Bartasek, Senior Associate Director, Global Pharmacovigilance, Boehringer Ingelheim Pharma GmbH & Co. KG
Josué Bautista Arteaga, GCP/PV Auditor, Novartis
Kelly Benner, Director, Safety Policy & Process Oversight Lead (PV Policy), Janssen Inc
Melissa Bernal, Vice President, Asociación Colombiana de Farmacovigilancia
Fatima Bhayat, Vice President, Head of Global Patient Safety and Chief Safety Officer, Amgen Inc
Arpita Bhowmick, Director, Global Omni Channel Contact Center Technology, Digital, Digital Thought Leader
Kapil Bhutada, Senior Director, Quality and Compliance, Inozyme Pharma
William Blumentals, Head of Pharmacoepidemiology, Specialty Care, Sanofi
Bridgette Bolstridge, Senior Managing Consultant, Navitas Life Sciences
Chris Bone, Pharmacovigilance Scientist, Biogen
Rachel Bonfanti, Senior Director, Risk Management & Scientific Consulting, UBC
Janaina Brothers, Manager, Aggregate Report Analyst, Pfizer
Benjamin Brown, Executive Director, American Society of Pharmacovigilance
Rachel Brummert, Communications Lead, American Society of Pharmacovigilance
Preston Burns, Interactive Safety Graphics working group; Principal Data Scientist, Sarepta Therapeutics
Cathy Cather, Chief Executive Officer, Parallel Profile
K. Arnold Chan, Senior Vice President, Insight & Evidence Generation, TriNetX
David Chonzi, Global Head of PVE, Instil Bio
Elizabeth Ciyou-Allee, Senior Director of Safety Operations and Infrastructure, Day One Biopharmaceuticals
Abimbola Cole, Scientific Director, Safety Evaluation & Risk Management (SERM), GSK
Brian Curci, Associate Partner, Life Science, IBM
Joan D’souza, Medical Reviewer; President, ISoP Swiss and Austria
Juan Daccach MD, Vice President, Global Product Safety, Merz Aesthetics
Sean Darcy, Principal & Founder, Darcy Consulting Group
Michelle Motta Dardeno, Vice President and Head - Global Patient Safety, Aurinia
Vidhya Dattarajan, Associate Director, Accenture
Kourtney Davis, Vice President, Global Epidemiology, Janssen R&D
Barbara Dawson, Vice President, Head of Pharmacovigilance Operations, GSK
Tanmay Desai, Acting Head, Global PV Operations, Kyowa Kirin
Christina Dickson, Vice President and Head of US and Regions PV, GSK
Steve Dingman, Vice President, Head of Pharmacovigilance, ImmunoGen Inc
Nancy Dubois, Head of Global Patient Safety, US Region, EMD serono
Helen Edelberg, MD, MPH, Deputy Office Director for Safety, Office of New Drugs, FDA
Brian Edwards, Benefit Risk Assessment Planning working group; Managing Director, Husoteria Ltd; Vice President, International Society of Pharmacovigilance (ISoP)
Kal Elhoregy, Director, Global Risk Management & Pharmacovigilance Compliance, Global Patient Safety, Amneal Pharmaceuticals
Joe Elicone, Global Business Process and Technology Lead, CSL Behring
Katie Ellis, Senior Manager, US Patient Safety Operations, EMD serono
Joann Evangelista, Head of US Patient Safety Operations & Innovations, Genentech, a Member of the Roche Group
Kevin Fetterman, Exec Director, Client Engagement, Orbit By Feith Systems
Marie Flanagan, Director, Offering Management, IQVIA Vigilance Detect
Peg Fletcher, Head of Early Development & Investigational Safety, President, MedAssessment, Inc.
Scott Fonseca, Vice President, Integrated Safety Managing, IQVIA
Sarah Frise, Global Head Safety Epidemiology and Risk Management, AstraZeneca
Joshua Gagne, Vice President and Global Head of Epidemiology, Johnson & Johnson
Antara Gaur, Senior Director, Pinnaxis
Jacqueline Gerena, Director, Risk Management Strategy, Janssen
Amrit Gill, Therapeutic Area Head, Sanofi
Juan Camilo Gonzalez, Head Pharmacovigilance Operations, Moderna
Sophia Goodison, Senior Director, Oncology, Cell and Gene Therapy, SERM, GSK
Aaron Goodstein, Senior Director, Medical Safety Operations & Strategy, Johnson and Johnson Medical Devices
Robert Gordon, Director Biostatistics, Janssen
Alejandra Guerchicoff, Industry Leader, TCS ADD™ Safety, Tata Consultancy Services
Israel Gutierrez, Chief Medical Officer, TLR Therapeutics
Sepideh Habibi, Head of Global Pharmacovigilance and RM, CRISPR Therapeutics
Bill Haddock, Head Of Safety, Ovid Therapeutics
Connor Haslam, Chief Executive Officer, Microdose Psychedelic Insight
Alia Hawkes, Executive Director, Head of Global Patient Safety, Arcturus Therapeutics
Famina Hemani, Executive Director, Drug Safety and Pharmacovigilance, Biosplice Therapeutics
Barbara Hendrickson MD, Aggregate Safety Assessment Planning (ASAP) working group; Department of Pediatrics, University of Chicago
Garrett Hess, Director Product Marketing, Safety & Medical Affairs, ArisGlobal LLC
Kevin Holman, Senior Director, REMS and Risk Management, Scientific Affairs, Janssen
Nanci Horovitz, Director, Safety Policy & Process Oversight Lead (PV Policy), Janssen Inc
Deidre Ifill, Commercial Sales and Patient Access Specialist, Independent
Ajinkya Inamdar, Senior Director (Global Medical Safety Strategy), BioNTech SE
Dutrochet Jacques Djoko, Associate Director, Global Medical Reviewer, Sarepta Therapeutics
Amit Jain, Founder and Director of US Ops., Ultragenic Research & Technologies LLC
Walter Jones, Professor of Molecular Pharmacology & Neuroscience; Director of Pharmacovigilance Programs, Loyola University Chicago
Prashant Joshi, Executive Director, Drug Safety, Fortrea
Namita Joshi, CHC Global Case Management Head, Sanofi-Opella
Dejan Juric, Director, Program And Investigational Cancer Therapeutics Program, Massachusetts General Hospital
Vineet Kacker, Managing Director & Global Technical Head, APCER Life Sciences
Mamiko Kasho, Executive Director, Eisai
Amanda Kesner-Hays, Senior Director, Safety Science, Corcept Therapeutics
Vikalp Khare, Director, Global Safety Data Management, GPV, Otsuka Pharmaceutical
Alexandre Kiazand, Global Head, Patient Safety Vaccine & Immune Therapies, Astrazeneca
Kostas Kidos, Vice President, Head Global Patient Safety Operations, Takeda Pharmaceuticals
Meredith Kiley, Senior PV Operations Manager, US Patient Safety, Genentech
Ryan Kilpatrick, Vice President & Head, Global Epidemiology, AbbVie
Christina Kim, Senior Director, Vault Safety, Veeva Systems
Peter Kohut, Pharmacovigilance Director, Alvotech
Michael Kruczek, Senior Director of Vault Safety Strategy, Veeva Systems
Robert Kyle, VP, Product Management, TriNetX
Graeme Ladds, Director of Pharmacovigilance & Chief Executive Officer, PharSafer
Fabio Lievano, Vice President Safety Science, Abbvie Pharmaceuticals Inc
Beth MacEntee Pileggi, Senior Director, Safety Information Management & Automation, Johnson and Johnson
Philisha Mack, Director Drug Safety, Azurity Pharmaceuticals
Sumathi Madadi, Associate Director, Bristol-Myers Squibb
Asif Mahmood, Vice President Medical Safety & Pharmacovigilance, Asklepios BioPharmaceutical Inc
Ashish Mangal, Associate Director, Pinnaxis
Susan Mather, MD, Senior Director, Pfizer
Bruno Mendez, VP, Global quality PV, Sanofi
Sherry Mills, President and CEO, ADROIT Risk Management
Priyavadhana Moka, Patient Safety Specialist, EMD Serono Inc
Madhu Mondal, Head of Toxicology, Senior Director, Cerevel Therapeutics
Deanna Montes de Oca, Senior Director PV Operations -Case Management, Moderna Therapeutics
Michael Murphy, Associate Vice President, Head of Pharmacovigilance Operations, Amgen
Narayan Nair, Division Director for Division of Pharmacovigilance, Center for Biologics Evaluation and Research, U.S. Federal Drug Administration
Jaylaxmi Nalawade, Director – Pharmacovigilance and REMS, Lupin
Narayanan R. Naru, Chief Architect and Head of Clinical & Safety Platforms, TCS ADD™, Tata Consultancy Services
Taj Nero, Risk Management Associate Lead, Janssen
Lina Ogbu, Medical Director Patient Safety and Pharmacovigilance, Arcus Biosciences
Nneka Okere, Senior Director, Pharmacovigilance, Nurix Therapeutics
Bruce Palsulich, Vice President, Safety, Oracle Life Sciences
Vartika Pandya, Strategy Insights & Planning Manager, ZS ASSOCIATES
Karthik Babu Parasumanna Sudarsan, CHC Global PV Operations Head, Sanofi
Nico Patel, US Risk Management Expert, Sanofi
Gerson Peltz, Senior Vice President of Patient Safety & Pharmacovigilance, Arcus Biosciences Inc
Mark Perrott, Founder, Managing Partner, Axian Consulting Ltd.
Elena Persiantsev, Director, Life Sciences Sales, Welocalize
Jan Petracek, Chief Executive Officer, iVigee
Rupesh Kumar Polupongu, Senior Manager, Global Safety Data Management, Otsuka Pharmaceutical
Kimary Pomphrett, Associate Vice President, Client Services, Techsol Life Sciences
John Price, Vice President of Continuing Medical Education, American Society of Pharmacovigilance Physicians
Humaira Qureshi, President, Qinecsa Solutions
Elena Carmen Radu, Senior Global Drug Safety Physician, Basilea Pharmaceutica International Ltd.
Sandeepa Raina, Senior Director, IT Business Partner Worldwide Patient Safety, Bristol-Myers Squibb
Deiva Ramachandran, Partner, IBM
Ramesh Rayaroth Mamangalavan, Sr. Business Partnering Lead, Astrazeneca
Arie Regev, Vice President, Medical Global Patient Safety, Lilly and Company
Sharon Reid, Senior Manager, Product Analyst, Risk Management Product Lead (SSRM), Pfizer
Michel Rempel, Senior Director, Client Services, Pharmacovigilance, UBC
Sara Rogers,PharmD, BCPS, President, American Society of Pharmacovigilance
Angela Caro Rojas, President, International Society of Pharmacovigilance (ISoP)
Cibele Rudge, Director of Global Single Case Processing, Haleon
Maha Saad, PhD, MBA, Senior Director, Drug Safety & Pharmacovigilance, Atara Biotherapeutics
Satya Sagi, Founder & Chief Executive Officer, Techsol Life Sciences
Philip Schneider, Advisory Board Chair, Alliance for Safe Biologic Medicines
Grishma Sharma, Managing Director, Accenture LLP
Maria Shkrob, Consultant, Professional Services, ELSEVIER
Karam Veer Singh (KV), Head of Global Markets, Solutions & Partnerships, Tata Consultancy Services
Elizabeth Smalley, Director, Product Management Data and Analytics, ArisGlobal LLC
Mark Stewart, Vice President, Science Policy, Friends of Cancer Research
Carmit Strauss, Executive Director, Head of Risk Management and Organ Toxicity, Takeda
Kevin Sullivan, Principal, Deloitte
Mitra Tavakkoli, Vice President; Clinical Development, 4DMT
Maria Tello, Senior Medical Director, Patient Safety & PV Lead, Strategy and Innovation, Horizon
Tarak Thakker, Head of Safety Systems, BeiGene
Sameer Thapar, Global Head & Strategic Advisor, Oracle Life Sciences
Siva Thiagarajan, Principal, ZS ASSOCIATES
Pradeep Tirumalaraju, Senior Manager, Information Management Safety Solutions, Pfizer
Sam Tomlinson, Vice President of Global Drug Safety, Arriello
Kelly Traverso, Vice President, Sales Executive, Deloitte
Phil Tregunno, Deputy Director, Patient Safety Monitoring, Medicines & Healthcare products Regulatory Agency
Uwe Trinks, Global Practice Lead, Iqvia
Karen Tucker, Associate Director, Safety Policy & Process Oversight (PV Policy), Janssen Inc
Donna Valencia, Vice President, Head of Drug Safety, Immune-Onc Therapeutics
Martijn van de Leur, Chief Operating Officer PV/RA/MI, Biomapas
Liliana Vargas Neri, President of Latin American Chapter, International Society of Pharmacovigilance (ISoP)
Dennis Vargo, Independent PV Expert
Sriram Varma, Co-Founder & Senior Vice President, Technology & Data, Techsol Life Sciences
Ale (Maria) Vazquez, Senior Vice President & Head Medical Safety Science, Astellas Pharma
Sumit Verma, President, Clinical Safety and PV, Soterius, Inc.
Javier Waksman, Vice President, Head Of Global Drug Safety, Cerevel Therapeutics
Aman Wasan, Chief Commercial Officer, ArisGlobal LLC
Brian Waterhouse, Benefit Risk Assessment Tool Suite (BRATS) working group; Senior Principal Scientist, Merck
Daniel Welper, Senior Director, Clinical Safety and Risk Management, Astex Pharmaceuticals
Susan Welsh MD, Senior Vice President, PV & Chief Safety Officer, Mirati Therapeutics
Matthew Wieczorek, Director / PSMF Lead, Quality Management & Inspections, Pfizer
Kelly Wilson, Senior Manager PV Operations - Global Case Management, Moderna
Marie-Claire Wilson, Engagement Manager, Axian Consulting Ltd.
Richard Wolf, PV Professional
Beena Wood, Senior Vice President, Safety & Medical Affairs Product Management, ArisGlobal LLC
Keele Wurst, Head Safety Science, Epidemiology, GlaxoSmithKline
Syed Zafeeruddin, Global Pharmacovigilance Manager and QPPV, Julphar
Jinfeng Zhang, Professor, Florida State University
Oleg Zvenigorodsky, Director, Medical Safety / Innovation Lead, Jazz Pharmaceuticals
Get Involved At Drug Safety Congress Americas
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events